{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:00:31Z","timestamp":1793642431069,"version":"4.5.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.revmed.2022.12.004","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T15:17:38Z","timestamp":1674487058000},"page":"62-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["French practical guidelines for the diagnosis and management of AA amyloidosis"],"prefix":"10.1016","volume":"44","author":[{"given":"S.","family":"Georgin-Lavialle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Savey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Buob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"Bastard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fellahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Karras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-J.","family":"Boffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Grateau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2022.12.004_bib0155","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2022.12.004_bib0160","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.nephro.2017.03.001","article-title":"[AA amyloidosis]","volume":"13","author":"Stojanovic","year":"2017","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.revmed.2022.12.004_bib0165","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.rdc.2018.06.004","article-title":"Amyloidosis","volume":"44","author":"Papa","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.revmed.2022.12.004_bib0170","doi-asserted-by":"crossref","first-page":"w13580","DOI":"10.4414\/smw.2012.13580","article-title":"AA amyloidosis: basic knowledge, unmet needs and future treatments","volume":"142","author":"Obici","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.revmed.2022.12.004_bib0175","first-page":"S46","article-title":"Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature","volume":"33","author":"Lane","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2022.12.004_bib0180","first-page":"133","article-title":"Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis","volume":"14","author":"Hazenberg","year":"2007","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"key":"10.1016\/j.revmed.2022.12.004_bib0185","first-page":"1","article-title":"Causes of AA amyloidosis: a systematic review","volume":"27","author":"Brunger","year":"2020","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"key":"10.1016\/j.revmed.2022.12.004_bib0190","article-title":"Identification of factors for persistence of AA amyloidosis in patients with Familial Mediterranean Fever","author":"Terr\u00e9","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.revmed.2022.12.004_bib0195","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.kint.2021.09.007","article-title":"A mutation in the SAA1 promoter causes hereditary amyloid A amyloidosis","volume":"101","author":"Sikora","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.revmed.2022.12.004_bib0200","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.revmed.2018.02.005","article-title":"[Familial Mediterranean fever]","volume":"39","author":"Georgin-Lavialle","year":"2018","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2022.12.004_bib0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/13506129.2018.1429391","article-title":"Obesity is a significant susceptibility factor for idiopathic AA amyloidosis","volume":"25","author":"Blank","year":"2018","journal-title":"Amyloid"},{"key":"10.1016\/j.revmed.2022.12.004_bib0210","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.ejim.2017.02.004","article-title":"AA amyloidosis is an emerging cause of nephropathy in obese patients","volume":"39","author":"Stankovic Stojanovic","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.revmed.2022.12.004_bib0215","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2022.12.004_bib0220","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1093\/rheumatology\/keab683","article-title":"VEXAS syndrome-related AA amyloidosis: a case report","volume":"61","author":"Euvrard","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.revmed.2022.12.004_bib0225","first-page":"255","article-title":"[Validation of the usual values provided by a supplier without access to a control population: example of serum amyloid A]","volume":"77","author":"Fellahi","year":"2019","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.revmed.2022.12.004_bib0230","doi-asserted-by":"crossref","first-page":"w13580","DOI":"10.4414\/smw.2012.13580","article-title":"AA amyloidosis: basic knowledge, unmet needs and future treatments","volume":"142","author":"Obici","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.revmed.2022.12.004_bib0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2020.08.012","article-title":"Cause of death and risk factors for mortality in AA amyloidosis: A French retrospective study","author":"Terr\u00e9","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.revmed.2022.12.004_bib0240","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(00)05252-1","article-title":"Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein","volume":"358","author":"Gillmore","year":"2001","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.revmed.2022.12.004_bib0245","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/13506129.2017.1352503","article-title":"Safety and efficacy of empirical interleukin-1 inhibition using anakinra in AA amyloidosis of uncertain aetiology","volume":"24","author":"Lane","year":"2017","journal-title":"Amyloid"},{"key":"10.1016\/j.revmed.2022.12.004_bib0250","doi-asserted-by":"crossref","first-page":"661101","DOI":"10.3389\/fmed.2021.661101","article-title":"Successful treatment of AA Amyloidosis in Ankylosing Spondylitis Using Tocilizumab: report of two cases and review of the literature","volume":"8","author":"Eriksson","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.revmed.2022.12.004_bib0255","doi-asserted-by":"crossref","first-page":"e7859","DOI":"10.1097\/MD.0000000000007859","article-title":"Long-term follow-up of secondary amyloidosis patients treated with tumor necrosis factor inhibitor therapy: A STROBE-compliant observational study","volume":"96","author":"Esatoglu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2022.12.004_bib0260","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10157-016-1271-y","article-title":"Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience","volume":"21","author":"Ozawa","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.revmed.2022.12.004_bib0265","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3389\/fimmu.2020.00971","article-title":"The use of interleukine-1 inhibitors in familial mediterranean fever patients: a narrative review","volume":"11","author":"Hentgen","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.revmed.2022.12.004_bib0270","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/2000-1967-142","article-title":"Effect of losartan treatment on the proteinuria in normotensive patients having proteinuria due to secondary amyloidosis","volume":"106","author":"Odabas","year":"2001","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.revmed.2022.12.004_bib0275","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/003655902762467602","article-title":"Long-term effects of losartan on proteinuria and renal function in patients with renal amyloidosis","volume":"36","author":"Dilek","year":"2002","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.revmed.2022.12.004_bib0280","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1111\/j.1600-6143.2011.03620.x","article-title":"Renal transplantation in patients with AA amyloidosis nephropathy: results from a French multicenter study","volume":"11","author":"Kofman","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.revmed.2022.12.004_bib0285","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1600-6143.2012.04326.x","article-title":"Renal transplantation in systemic amyloidosis-importance of amyloid fibril type and precursor protein abundance","volume":"13","author":"Pinney","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.revmed.2022.12.004_bib0290","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/ard.62.10.916","article-title":"Reproductive system in familial Mediterranean fever: an overview","volume":"62","author":"Ben-Chetrit","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2022.12.004_bib0295","first-page":"243","article-title":"The effect of pregnancy on renal function in amyloidosis of familial Mediterranean fever","volume":"28","author":"Cabili","year":"1992","journal-title":"Am J Reprod Immunol N Y N 1989"},{"key":"10.1016\/j.revmed.2022.12.004_bib0300","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3109\/0886022X.2013.846863","article-title":"Pregnancy outcome of five patients with renal amyloidosis regarding familial Mediterranean fever","volume":"36","author":"Turgal","year":"2014","journal-title":"Ren Fail"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866322011821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866322011821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:46:12Z","timestamp":1759337172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866322011821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0248866322011821"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2022.12.004","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"French practical guidelines for the diagnosis and management of AA amyloidosis","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2022.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}